The phase 3 Clinical Assessment of phaRmacokinetics, Efficacy, Safety of a 10% Ig (CARES10) study was designed to evaluate the safety, efficacy, and pharmacokinetics of a 10% intravenous immunoglobulin in…
Erica Billy discusses her experience caring for her daughter who has severe combined immunodeficiency (SCID). Ava had a fever at birth, which was their first indication that she…
Benjamin Prince, MD, MSCI, FAAAAI, allergist/immunologist at Nationwide Children’s Hospital in Columbus, Ohio, discusses when to consider starting IgG replacement therapy. IgG replacement therapy is pooled antibody from…
Benjamin Prince, MD, MSCI, FAAAAI, allergist/immunologist at Nationwide Children’s Hospital in Columbus, Ohio, discusses primary immunodeficiency diseases. Many patients have a genetic defect that results in part of…
ER visits related to food allergy in infants and toddlers 0 to 4 years of age have risen in recent years. In this video, Vivian Hernandez-Trujillo, MD discusses…
Philip Goulder, a professor of immunology at the University of Oxford, is currently investigating why a significant subsection of HIV-positive children in sub-Saharan Africa seem to have resisted…
Epstein-Barr virus (EBV), similar to other common viruses, remains in the body indefinitely after exposure and requires constant monitoring by the immune system in order to effectively to…